Analyst Ratings for ANI Pharmaceuticals (ANIP)
ANIP Rating Summary
ANIP Price Target Summary
- Highest: $124.00 (Guggenheim)
- Lowest: $90.00 (Truist Securities)
- Average: $106.43
* Over Last 12-Mos
Overall Rating:
BUY
Rating Trend:
Avg. $ Target:
$106.43 (+41.5%)
* Over Last 12-Mos
Rating Score: 7.9 / 10
Percentile Rank: 82%
Avg. $ Target:
$106.43 (+41.5%)
* Over Last 12-Mos
Rating Score: 7.9 / 10
Percentile Rank: 82%
| Date | Firm | Analyst | Type | Rating (Past) |
PT (Past) |
Start $ (End $) |
% Chg. | Details |
|---|---|---|---|---|---|---|---|---|
| 7/10/2025 | H.C. Wainwright » Updated 8/11/2025 |
Brandon Folkes | New Coverage | Buy (N/A) |
93.00 (84.00) |
65.31 (75.23) |
15.19% | Details |
| 3/14/2025 | Jefferies » Updated 3/31/2026 |
Dennis Ding | New Coverage | Buy (N/A) |
120.00 (N/A) |
63.26 (75.23) |
18.92% | Details |
 |
||||||||
|
||||||||
|
||||||||
|
||||||||
|
||||||||
|
||||||||
|
||||||||
|
||||||||
